Skip to main content
Erschienen in: Heart and Vessels 1/2011

01.01.2011 | Original Article

Effect of mini-tyrosyl-tRNA synthetase/mini-tryptophanyl-tRNA synthetase on ischemic angiogenesis in rats: proliferation and migration of endothelial cells

verfasst von: Rui Zeng, Yu-cheng Chen, Zhi Zeng, Wei-qiang Liu, Xiao-fei Jiang, Rui Liu, Ou Qiang, Xian Li

Erschienen in: Heart and Vessels | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to determine the mechanism of mini-tyrosyl-tRNA synthetase/mini-tryptophanyl-tRNA synthetase (mini-TyrRS/mini-TrpRS) on ischemic angiogenesis in rats with acute myocardial infarction and proliferation, migration, potential signaling pathways of rat coronary venular endothelial cells (RCVECs). The effects of mini-TyrRS/mini-TrpRS on RCVECs proliferation were evaluated using the MTT colorimetric assay. Cell migration was assayed using a modified Boyden chamber technique. The potential involvement of Erk and PI3K signaling pathways was explored using selective chemical inhibitor or Western-blot analysis. Left coronary artery ligation was used to establish the model of acute myocardial infarction in rats (Sprague-Dawley male rats, 200–250 g, 2–3 months old), 20 μl of mini-TyrRS, mini-TrpRS, or PBS (vehicle) was injected subcutaneously every 12 h. The rats were randomly divided into four experimental groups: sham operated group; coronary artery ligation (CAL); CAL + mini-TyrRS (20 μl, twice daily, 600 μg kg−1 day−1); and CAL + mini-TrpRS (20 μl, twice daily, 600 μg kg−1 day−1). The experiment was carried out at four time points on the 3rd, 7th, 14th, and 28th day after ligation. To determine whether mini-TyrRS/mini-TrpRS affected the angiogenesis activity of rats with myocardial infarction, we measured the myocardial infarction size by TTC staining, and microvessel density (MVD) was determined by CD34 staining. The results show that proliferation and migration in RCVECs could be promoted by mini-TyrRS at concentrations of 1–100 μg/ml, and inhibited by mini-TrpRS. Phospho-PI3-kinase and Erk expression increased significantly when mini-TyrRS was added, but could be attenuated by mini-TrpRS. Compared to the CAL group, the myocardial infarction size of the mini-TyrRS group at the 3rd, 7th, 14th, and 28th day were decreased, while mini-TrpRS increased, but only in days 14 and 28 was there a significant difference. Except that, the microvessel density of RCVECs was promoted in mini-TyrRS group but inhibited in the mini-TrpRS group. These results indicated that angiogenesis could be either stimulated by mini-TyrRS or inhibited by mini-TrpRS.
Literatur
1.
Zurück zum Zitat Shiny KS, Kumar SH, Farvin KH, Anandan R, Devadasan K (2005) Protective effect of taurine on myocardial antioxidant status in isoprenaline-induced myocardial infarction in rats. J Pharm Pharmacol 57:1313–1317CrossRefPubMed Shiny KS, Kumar SH, Farvin KH, Anandan R, Devadasan K (2005) Protective effect of taurine on myocardial antioxidant status in isoprenaline-induced myocardial infarction in rats. J Pharm Pharmacol 57:1313–1317CrossRefPubMed
2.
Zurück zum Zitat Gach O, Louis O, Chapelle JP, Vanbelle S, Pierard LA, Legrand V (2009) Baseline inflammation is not predictive of periprocedural troponin elevation after elective percutaneous coronary intervention. Heart Vessels 24:267–270CrossRefPubMed Gach O, Louis O, Chapelle JP, Vanbelle S, Pierard LA, Legrand V (2009) Baseline inflammation is not predictive of periprocedural troponin elevation after elective percutaneous coronary intervention. Heart Vessels 24:267–270CrossRefPubMed
3.
Zurück zum Zitat Laham RJ, Sellke FW, Edelman JD, Pearlman JD, Ware A, Brown DL, Gold JP, Simons M (1999) Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 100:1865–1871PubMed Laham RJ, Sellke FW, Edelman JD, Pearlman JD, Ware A, Brown DL, Gold JP, Simons M (1999) Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 100:1865–1871PubMed
4.
Zurück zum Zitat Horii M, Uemura S, Uemura M, Matsumoto M, Ishizashi H, Imagawa K, Iwama H, Takeda Y, Kawata H, Nakajima T, Fujimura Y, Saito Y (2008) Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation. Heart Vessels 23:301–307CrossRefPubMed Horii M, Uemura S, Uemura M, Matsumoto M, Ishizashi H, Imagawa K, Iwama H, Takeda Y, Kawata H, Nakajima T, Fujimura Y, Saito Y (2008) Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation. Heart Vessels 23:301–307CrossRefPubMed
5.
Zurück zum Zitat Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom OW, Crystal RG (1999) Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100:468–474PubMed Rosengart TK, Lee LY, Patel SR, Sanborn TA, Parikh M, Bergman GW, Hachamovitch R, Szulc M, Kligfield PD, Okin PM, Hahn RT, Devereux RB, Post MR, Hackett NR, Foster T, Grasso TM, Lesser ML, Isom OW, Crystal RG (1999) Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100:468–474PubMed
6.
Zurück zum Zitat Symes JF, Losordo DW, Vale PR, Lathi KG, Esakof DD, Maysky M, Isner JM (1999) Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 68:830–837CrossRefPubMed Symes JF, Losordo DW, Vale PR, Lathi KG, Esakof DD, Maysky M, Isner JM (1999) Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 68:830–837CrossRefPubMed
7.
Zurück zum Zitat Vale PR, Losordo DW, Milliken CE, McDonald MC, Gravelin LM, Curry CM, Esakof DD, Maysky M, Symes JF, Isner JM (2001) Randomized, singe-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 103:2138–2143PubMed Vale PR, Losordo DW, Milliken CE, McDonald MC, Gravelin LM, Curry CM, Esakof DD, Maysky M, Symes JF, Isner JM (2001) Randomized, singe-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 103:2138–2143PubMed
8.
Zurück zum Zitat Wakasugi K, Schimmel P (1999) Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science 284:147–151CrossRefPubMed Wakasugi K, Schimmel P (1999) Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science 284:147–151CrossRefPubMed
9.
Zurück zum Zitat Martinis SA, Plateau P, Cavarelli J, Florentz C (1999) Aminoacyl-tRNA synthetases: a family of expanding functions. EMBO J 18:4591–4596CrossRefPubMed Martinis SA, Plateau P, Cavarelli J, Florentz C (1999) Aminoacyl-tRNA synthetases: a family of expanding functions. EMBO J 18:4591–4596CrossRefPubMed
11.
Zurück zum Zitat Lee SW, Cho BH, Park SG, Kim S (2004) Aminoacyl-tRNA synthetase complexes: beyond translation. J Cell Sci 117:3725–3734CrossRefPubMed Lee SW, Cho BH, Park SG, Kim S (2004) Aminoacyl-tRNA synthetase complexes: beyond translation. J Cell Sci 117:3725–3734CrossRefPubMed
12.
Zurück zum Zitat Park S, Kim S (2006) Do aminoacyl-tRNA synthetases have biological functions other than in protein biosynthesis? IUBMB Life 58:556–558CrossRefPubMed Park S, Kim S (2006) Do aminoacyl-tRNA synthetases have biological functions other than in protein biosynthesis? IUBMB Life 58:556–558CrossRefPubMed
13.
Zurück zum Zitat Wakasugi K, Slike BM, Hood J, Ewalt KL, Cheresh DA, Schimmel P (2002) Introduction of angiogenesis by a fragment of human tyrosyl-tRNA synthetase. J Biol Chem 277:20124–20126CrossRefPubMed Wakasugi K, Slike BM, Hood J, Ewalt KL, Cheresh DA, Schimmel P (2002) Introduction of angiogenesis by a fragment of human tyrosyl-tRNA synthetase. J Biol Chem 277:20124–20126CrossRefPubMed
14.
Zurück zum Zitat Wakasugi K, Slike BM, Hood J, Otani A, Ewalt KL, Friedlander M, Cheresh DA, Schimmel P (2002) A human aminoacyl-tRNA synthetase as a regulator of angiogenesis. Proc Natl Acad Sci 99:173–177CrossRefPubMed Wakasugi K, Slike BM, Hood J, Otani A, Ewalt KL, Friedlander M, Cheresh DA, Schimmel P (2002) A human aminoacyl-tRNA synthetase as a regulator of angiogenesis. Proc Natl Acad Sci 99:173–177CrossRefPubMed
15.
Zurück zum Zitat Ewalt KL, Schimmel P (2002) Activation of angiogenic signaling pathways by two human tRNA synthetases. Biochemistry 41:13344–13349CrossRefPubMed Ewalt KL, Schimmel P (2002) Activation of angiogenic signaling pathways by two human tRNA synthetases. Biochemistry 41:13344–13349CrossRefPubMed
16.
Zurück zum Zitat Wakasug K, Schimmel P (1999) Highly differentiated motifs responsible for two cytokine activities of a split human tRNA synthetase. J Biol Chem 274:23155–23159CrossRef Wakasug K, Schimmel P (1999) Highly differentiated motifs responsible for two cytokine activities of a split human tRNA synthetase. J Biol Chem 274:23155–23159CrossRef
17.
Zurück zum Zitat Otani A, Slike BM, Dorrell M, Hood J, Kinder K, Ewalt KL, Cheresh D, Schimmel P, Friedlander M (2002) A fragment of human TrpRS as a potent antagonist of ocular angiogenesis. Proc Natl Acad Sci USA 99:178–183CrossRefPubMed Otani A, Slike BM, Dorrell M, Hood J, Kinder K, Ewalt KL, Cheresh D, Schimmel P, Friedlander M (2002) A fragment of human TrpRS as a potent antagonist of ocular angiogenesis. Proc Natl Acad Sci USA 99:178–183CrossRefPubMed
18.
Zurück zum Zitat Fleckner J, Martensen PM, Tolstrup AB, Kjeldgaard NO, Justesen J (1995) Differential regulation of the human interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines. Cytokine 7:70–77CrossRefPubMed Fleckner J, Martensen PM, Tolstrup AB, Kjeldgaard NO, Justesen J (1995) Differential regulation of the human interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines. Cytokine 7:70–77CrossRefPubMed
19.
Zurück zum Zitat Jorgensen R, Sogaard TM, Rossing AB, Martensen PM, Justesen J (2000) Identification and characterization of human mitochondrial tryptophanyl-tRNA synthetase. J Biol Chem 275:16820–16826CrossRefPubMed Jorgensen R, Sogaard TM, Rossing AB, Martensen PM, Justesen J (2000) Identification and characterization of human mitochondrial tryptophanyl-tRNA synthetase. J Biol Chem 275:16820–16826CrossRefPubMed
20.
Zurück zum Zitat Kise Y, Lee SW, Park SG, Fukai S, Sengoku T, Ishii R, Yokoyama S, Kim S, Nureki O (2004) A short peptide insertion crucial for angiostatic activity of human tryptophanyl-tRNA synthetase. Nat Struct Mol Biol 11:149–156CrossRefPubMed Kise Y, Lee SW, Park SG, Fukai S, Sengoku T, Ishii R, Yokoyama S, Kim S, Nureki O (2004) A short peptide insertion crucial for angiostatic activity of human tryptophanyl-tRNA synthetase. Nat Struct Mol Biol 11:149–156CrossRefPubMed
21.
Zurück zum Zitat Sladowski D, Steer SJ, Clothier RH, Balls M (1993) An improved MTT assay. J Immunol Methods 157:203–207CrossRefPubMed Sladowski D, Steer SJ, Clothier RH, Balls M (1993) An improved MTT assay. J Immunol Methods 157:203–207CrossRefPubMed
22.
Zurück zum Zitat Lin P, Welch EJ, Gao XP, Malik AB, Ye RD (2005) Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. J Immunol 174:2981–2989PubMed Lin P, Welch EJ, Gao XP, Malik AB, Ye RD (2005) Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. J Immunol 174:2981–2989PubMed
23.
Zurück zum Zitat Weidner KM, Sachs M, Birchmeier W (1995) Mutations of juxtamembrane tyrosine residue 1001 suppression loss-of-function mutations of the met receptor in epithelial cells. Proc Natl Acad Sci USA 92:2597–2601CrossRefPubMed Weidner KM, Sachs M, Birchmeier W (1995) Mutations of juxtamembrane tyrosine residue 1001 suppression loss-of-function mutations of the met receptor in epithelial cells. Proc Natl Acad Sci USA 92:2597–2601CrossRefPubMed
24.
Zurück zum Zitat Greenberg Y, King M, Ewalt K, Yang X, Schimmel P, Reader J, Tzima E (2008) The novel fragment of tyrosyl tRNA synthetase, mini-TyrRS, is secreted to induce an angiogenic response in endothelial cells. FASEB J 25:1597–1605 Greenberg Y, King M, Ewalt K, Yang X, Schimmel P, Reader J, Tzima E (2008) The novel fragment of tyrosyl tRNA synthetase, mini-TyrRS, is secreted to induce an angiogenic response in endothelial cells. FASEB J 25:1597–1605
25.
Zurück zum Zitat Biselli PM, Guerzoni AR, de Godoy MF, Pavarino-Bertelli EC, Goloni-Bertollo EM (2008) Vascular endothelial growth factor genetic variability and coronary artery disease in Brazilian population. Heart Vessels 23:371–375CrossRefPubMed Biselli PM, Guerzoni AR, de Godoy MF, Pavarino-Bertelli EC, Goloni-Bertollo EM (2008) Vascular endothelial growth factor genetic variability and coronary artery disease in Brazilian population. Heart Vessels 23:371–375CrossRefPubMed
26.
Zurück zum Zitat Nemes A, Forster T, Geleijnse M, Soliman OII, ten Cate FJ, Csanády M (2008) Prognostic value of coronary flow reserve and aortic distensibility indices in patients with suspected coronary artery disease. Heart Vessels 23:167–173CrossRefPubMed Nemes A, Forster T, Geleijnse M, Soliman OII, ten Cate FJ, Csanády M (2008) Prognostic value of coronary flow reserve and aortic distensibility indices in patients with suspected coronary artery disease. Heart Vessels 23:167–173CrossRefPubMed
Metadaten
Titel
Effect of mini-tyrosyl-tRNA synthetase/mini-tryptophanyl-tRNA synthetase on ischemic angiogenesis in rats: proliferation and migration of endothelial cells
verfasst von
Rui Zeng
Yu-cheng Chen
Zhi Zeng
Wei-qiang Liu
Xiao-fei Jiang
Rui Liu
Ou Qiang
Xian Li
Publikationsdatum
01.01.2011
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 1/2011
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-010-0032-1

Weitere Artikel der Ausgabe 1/2011

Heart and Vessels 1/2011 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.